Neoadjuvant Chemoradiation for Rectal Cancer: Analysis of Clinical Outcomes From a 13-Year Institutional Experience

Mark W. Onaitis, R. Barrett Noone, Matthew G. Hartwig, Herbert I. Hurwitz, Michael A. Morse, Paul S. Jowell, Kevin McGrath, Catherine Lee, Mitchell S. Anscher, Bryan M. Clary,

Annals of Surgery · 2001 · 157 citations · 35 references

DOIFull text

Open access

Abstract

Neoadjuvant chemoradiation is safe, effective, and well tolerated. Postoperative lymph node status is the only independent predictor of recurrence and survival.

References

35